Inhibitor of Apoptosis Proteins

doi:10.1017/CBO9780511976094.002

2 - Inhibitor of Apoptosis Proteins

from Part I - General Principles of Cell Death

Published online by Cambridge University Press: 07 September 2011

Douglas R. Green

Jason B. Garrison ,

Andreas Krieg ,

Kate Welsh ,

Yunfei Wen and

John C. Reed

Edited by

John C. Reed

Show author details

Douglas R. Green: Affiliation:
St. Jude Children's Research Hospital, Memphis, Tennessee
Jason B. Garrison: Affiliation:
Sanford-Burnham Medical Research Institute
Andreas Krieg: Affiliation:
Sanford-Burnham Medical Research Institute
Kate Welsh: Affiliation:
Sanford-Burnham Medical Research Institute
Yunfei Wen: Affiliation:
Sanford-Burnham Medical Research Institute
John C. Reed: Affiliation:
Sanford-Burnham Medical Research Institute
John C. Reed: Affiliation:
Sanford-Burnham Medical Research Institute, La Jolla, California

Book contents

Get access

Summary

Inhibitor of apoptosis proteins (IAPs) constitute a family of apoptosis-suppressing proteins that contain at least one copy of a conserved domain called baculoviral IAP repeat (BIR), a zinc-binding fold involved in protein interactions. Humans and other mammals contain multiple genes encoding IAP family members, providing a diversity of variants with both common and specialized functions. IAPs are known for their ability to bind certain caspases, which are proteases responsible for apoptosis. Several IAPs contain RING (really interesting new gene) domains that bind ubiquitin-conjugating enzymes (UBC), whereas others possess UBC catalytic domains. These attributes endow many IAPs with E3 ligase activity, implicating them in the ubiquitinylation and proteasome-dependent degradation of a variety of cellular substrates. In addition, several IAP family members have multifaceted functions as platforms for coordinating signal transduction events associated with activation of particular protein kinases. Finally, some IAPs have dual functions as regulators of cell death and cell division. In this chapter, we provide an overview of IAP family proteins, including their structures and domain organizations, biochemical and cellular functions, intracellular locations, post-translational modifications, and relevance to disease.

Type: Chapter
Information: Apoptosis
Physiology and Pathology
, pp. 11 - 22

DOI: https://doi.org/10.1017/CBO9780511976094.002 [Opens in a new window]

Publisher: Cambridge University Press

Print publication year: 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

Chai, J, Shiozaki, E, Srinivasula, SM, Wu, Q, Dataa, P, Alnemri, ES, Shi, Y. (2001) Structural basis of caspase-7 inhibition by XIAP. Cell 104:769–80.

Conte, D, Liston, P, Wong, JW, Wright, KE, Korneluk, RG. (2001) Thymocyte-targeted overexpression of XIAP transgene disrupts T lymphoid apoptosis and maturation. Proc Natl Acad Sci U S A 98:5049–54.

Conze, DB, Albert, L, Ferrick, DA, Goeddel, DV, Yeh, WC, Mak, T, Ashwell, JD. (2005) Posttranscriptional downregulation of c-IAP2 by the ubiquitin protein ligase c-IAP1 in vivo. Mol Cell Biol 25:3348–56.

Dan, HC, Sun, M, Kaneko, S, Feldman, RI, Nicosia, SV, Wang, HG, Tsang, BK, Cheng, JQ. (2004) Akt phosphorylation and stabilization of X-linked inhibitor of apoptosis protein (XIAP). J Biol Chem 279:5405–12.

Deveraux, QL, Reed, JC. (1999) IAP family proteins – suppressors of apoptosis. Genes Dev 13:239–52.

Deveraux, QL, Roy, N, Stennicke, HR, Van Arsdale, T, Zhou, Q, Srinivasula, SM, Alnemri, ES, Salvesen, GS, Reed, JC. (1998) IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J 17:2215–23.

Eckelman, BP, Salvesen, GS, Scott, FL. (2006). Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family. EMBO Rep 7:988–94.

Gyrd-Hansen, M, Darding, M, Miasari, M, Santoro, MM, Zender, L, Xue, W, Tenev, T, da Fonseca, PC, Zvelebil, M, Bujnicki, JM, Lowe, S, Silke, J, Meier, P. (2008) IAPs contain an evolutionarily conserved ubiquitin-binding domain that regulates NF-kappaB as well as cell survival and oncogenesis. Nat Cell Biol 10:1309–17.

Harlin, H, Reffey, SB, Duckett, CS, Lindsten, T, Thompson, CB. (2001) Characterization of XIAP-deficient mice. Mol Cell Biol 21:3604–8.

Hinds, MG, Norton, RS, Vaux, DL, Day, CL. (1999) Solution structure of a baculoviral inhibitor of apoptosis (IAP) repeat. Nat Struct Biol 6:648–51.

Hunter, AM, LaCasse, EC, Korneluk, RG. (2007) The inhibitors of apoptosis (IAPs) as cancer targets. Apoptosis 12:1543–68.

Joazeiro, CA, Weissman, AM. (2000) RING finger proteins: mediators of ubiquitin ligase activity. Cell 102:549–52.

Lu, M, Lin, SC, Huang, Y, Kang, YJ, Rich, R, Lo, YC, Myszka, D, Han, J, Wu, H. (2007) XIAP induces NF-kappaB activation via the BIR1/TAB1 interaction and BIR1 dimerization. Mol Cell 26:689–702.

Morgan, J, Yin, Y, Borowsky, A (1999) Breakpoints of the t(11;18)(q21;q21) in mucosa-associated lymphoid tissue (MALT) lymphoma lie within or near the previously undescribed gene MALT1 in chromosome 18. Cancer Res 59:6205–13.

O’Connor, DS, Grossman, D, Plescia, J, Li, F, Zhang, H, Villa, A, Tognin, S, Marchisio, PC, Altieri, DC. (2000) Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin. Proc Natl Acad Sci U S A 97:13103–17.

Oost, TK, Sun, C, Armstrong, RC, Al-Assaad, AS, Betz, SF, Deckwerth, TL, Ding, H, Elmore, SW, Meadows, RP, Olejniczak, ET, Oleksijew, A, Oltersdorf, T, Rosenberg, SH, Shoemaker, AR, Tomaselli, KJ, Zou, H, Fesik, SW. (2004) Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancer. J Med Chem 26:4417–26.

Perrelet, D, Ferri, A, Liston, P, Muzzin, P, Korneluk, RG, Kato, AC. (2002) IAPs are essential for GDNF-mediated neuroprotective effects in injured motor neurons in vivo. Nat Cell Biol 4:175–9.

Reed, JC. (2001) The Survivin saga goes in vivo. J Clin Invest 108:965–9.

Santoro, MM, Samuel, T, Mitchell, T, Reed, JC, Stainier, DY. (2007) Birc2 (cIap1) regulates endothelial cell integrity and blood vessel homeostasis. Nat Genet 39:1397–1402.

Srinivasula, SM, Ashwell, JD (2008) IAPs: What's in a name? Mol Cell 30:123–35.

Temesgen, S, Welsh, K, Lober, T, Togo, SH, Zapata, JM, Reed, JC. (2006) Distinct BIR domains of cIAP1 mediate binding to and ubiquitinylation of tumor necrosis factor receptor-associated factor 2 and second mitochondrial activator of caspases. J Biol Chem 281:1080–90.

Wang, Z, Cuddy, M, Samuel, T, Welsh, K, Schimmer, A, Hanaii, F, Houghten, R, Pinilla, C, Reed, JC. (2004) Cellular, biochemical, and genetic analysis of mechanism of small molecule IAP inhibitors. J Biol Chem 279:48168–76.

Ziegler, DS, Wright, RD, Kesari, S, Lemieux, ME, Tran, MA, Jain, M, Zawel, L, Kung, AL. (2008) Resistance of human glioblastoma multiforme cells to growth factor inhibitors is overcome by blockade of inhibitor of apoptosis proteins. J Clin Invest 118:3109–22.